chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2nd dose administered Thursday Jan 14th @ 2pm. Symptoms started  Friday Jan 15th  @ 0630 am. Became extremely lightheaded/dizzy. Became nauseous. Felt as I was going to pass out. Made it to bathroom as I thought I was going to vomit. Essentially collapsed on floor and had severe rigors/uncontrollable shaking throughout entire body for 30 minutes. Felt as I was being electrocuted, it was extremely intense and could feel it through every part of my body. Teeth were clenched entire time and could barely open mouth. Attempted to get up multiple times but could not make it past getting on my knees. Laid on floor  until shaking eventually subsided. Had severe headache after (i assume it was from clenching teeth for 30 min). Extreme fatigue.  Was sent to ER per policy for covid test - results negative. Sent home from work per policy. Slept remainder of day. Woke up @ 5 pm feeling substantially better.
7 hours post vaccine chills and fever began these persisted about 48 hours.  30 hours post vaccine swelling of injection site and extreme redness and bruising of upper arm. Painful to the touch but not itchy.
Patient returned to vaccine clinic approximately 2 hours after receiving vaccine reporting burning in her left arm where vaccine was received.  Patient reported to ED.  patient states buring from shoulder to fingers.  Patient reported to the ED provider that she has a nerve impingement in her cervical spine which does cause nerve pain down her arm from time to time.  Discharged from ED without further Issue.  patient given toradol in ED
On 4/19/99, the pt was vaccinated with MMR. On 5/19/99, the pt experienced unilateral parotitis with a temperature of 99.2 and tenderness and swelling. No further information is available.
Grandmother called to report child was seen at clinic on 12/8/03 due to "child crying all the time" since early AM. Reports going to ER at hospital at 8pm due to "stiffens up and cries all the time." Was hospitalized from 12/8/03 thru 12/24/03. Grandmother reports encephalitis.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site itching in a 61-year-old female patient who received SHINGRIX (batch number N9CA2, expiry date 2nd July 2021) for prophylaxis. On 11th February 2019, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site itching. On an unknown date, the outcome of the injection site itching was recovered/resolved. It was unknown if the reporter considered the injection site itching to be related to SHINGRIX. Additional details were provided as follows: The patient received 1st dose of SHINGRIX vaccine and had terrible itching in the injection arm for 5 days following the vaccination.
This spontaneous report as received from company representative from a physician refers to a female patient of unknown age. No pertinent medical history and concurrent conditions reported. On an unknown date the patient was vaccinated with GARDASIL (dose, route, lot# not reported). No concomitant medications reported. On an unknown date the patient was not able to get a dose with GARDASIL on the date she was scheduled to receive it because of a shipping problem resulting in an NCD# mismatch according to the documentation of the company vaccine assistance program. No adverse effects reported. This is one of the two reports received from the same reporter. Additional information has been requested.
Within 10 seconds I began to feel that something was wrong.   A full body response of a swirling congestion, extreme weakness. very blurry vision and couldn't think straight.  I had trouble walking to recovery room, felt nauseous and weak and had a very fast heartrate.  I had to stay in private recovery room for 45 min.  I was still very ill and nervous at this point.   I left with a family member and asked to be driven to the nearby hospital emergency room.  For a precaution .  We parked across from ER entrance for another 1 hour till I slowly regained strength to 50% normalcy.  I went home afterwards and had to go to bed. I was unable to drive my own vehicle home.  Day 2, still feel weak, shaky and not normal.  I consider this a serious adverse reaction that did not receive medical intervention but will prevent me from getting the second Pfizer shot.  After 5 hours post injection I felt 60% normal .  Day 2, 70 per cent normal.   The vaccination facility was not able to do blood pressure monitoring ( which is a problem for anyone experiencing reactions.)  They said their protocol was to call 911/ambulance.   My blood pressure was checked by a certified PA with professional equipment at the 3 hour post injection time and the diastolic pressure was still below 50.  And heart rate above normal.  Still weak and nauseous.
guesses the plunger was lose" and all the vaccine came out on the bottom.with no adverse event; some did get on her hand, but she washed it off immediately; Initial information was received on 8-Oct-2021 regarding an unsolicited valid non-serious case received from a pharmacist via regulatory authority (Information-00805079).  This case involves a patient of (unknown demographics) who was going for vaccination of suspect TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI] at that time of vaccine preparation guesses the plunger was lose and all the vaccine came out on the bottom (needle issue) and some did get on her hand, but she washed it off immediately (occupational exposure to product).  The patient's medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE (lot number T2A371M and expiry date 13-Apr-2022 were reported) via an unknown route at an unknown administration site for prophylactic vaccination.  It was a case of an actual medication error due to needle leak and occupational exposure via skin contact with product (latency was on same day).   At the time of report, no adverse event reported.   Outcome of events was unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Paralyzed with joint stiffness neck down for about 6 hours. Extreme joint stiffness Blood in urine
Pt started to "not feel well" about 5 minutes after her first dose.  She laid down on the ground before she fainted was never lost consciousness.  She began feeling back to normal after 5 minutes of laying down.
Had first covid shot 3/17/21 at 7:15. Got home started period around 2:00 pm. Period was two weeks early. Very heavy flow with awful cramps.   Had second Covid 19 vaccine today 4/7/21 at 7:25 and around 2:00-3:00 started period again. 1 week early.
given half dose of pfizer for booster when it should have been full dose .3cc this was corrected today when given full dose.
Patient's daughter descibed patient having severe pain at injection site, light headedness, and vomiting the next morning. Patient took Benadryl and symptoms stopped. No futher issues.
PERIPHERAL NEUROPATHY 12/1/2022 HTN (HYPERTENSION)
Patient presented with bright red skin with irregular borders on lower part of upper right arm NOT at injection site location.  Patient says the area "hurt" and began to develop right after her injection.
INCREDIBLE PAIN; MUSCLE ARE WEAK; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on JUN-2021 for prophylactic vaccination.The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced incredible pain, and muscle are weak. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the muscle are weak and incredible pain was not reported. This report was non-serious.
Patient developed lip tingling, tongue numbness and swelling, throat swelling.  EMS was contacted.  Patient chewed 50mg Benadryl and was given 3 doses of Epinephrine before EMS arrived.  Patient was stable when transported to ER.
Diarrhea / abdominal pain, beginning ~36 hours post-vaccination Injection site pain, beginning within a few hours, lasting a few days
51 employees had titers drawn; total of 9 had reduced or no immunity; pt did not respond p/3 doses of Engerix-B; HBSAB test indicated reduced immunity;
Thigh area where vaccine was given was reported hardened and bruised. No fever, no other concerns.
This case was reported by a nurse and described the occurrence of inappropriate schedule of vaccine administered in a 14-week-old male patient who received PEDIARIX (batch number 524HS, expiry date 29th August 2016). On 24th September 2014, the patient received PEDIARIX. On 24th September 2041, an unknown time after receiving PEDIARIX, the patient experienced inappropriate schedule of vaccine administered. On an unkonwn date, the outcome of the inappropriate schedule of vaccine administered was unknown. Additional information: HCP gave a 1st dose of PEDIARIX a little late from the recommended 2 month age. The patient was 3 month and 6 days old when received the 1st dose.
This spontaneous report as received from a physician refers to his 16 year old daughter. The patient was vaccinated with the first dose of GARDASIL (strength, dose, route and lot # were unknown) on an unspecified date about a year ago (approximately in March 2013), after which her menstrual periods became sparse. After the patient was administered a second dose of GARDASIL on an unspecified date the patient's regular menstrual periods stopped completely. The outcome of events was unknown. The relationship of events was unknown. Additional information has been requested.
After my first shot on April 3rd, 2021 Roughly 2-3 minutes after i experienced tunnel vision, dizziness, tachycardia, irregular heart beats. was told this was completely normal. symptoms subsided after about 10 minutes. Fast forward a few months in August i was on a plane flying and I had my first of many more heart arrhythmias. My heart sky rocketed to 181 bpm according to my watch. On September 17 i passed a stress test to rule out heart disease but was still symptomatic. Also received an echo in early october which showed normal function. After months of trying to narrow down the new found symptoms of arrhythmia, chest pain, gastritis, joint pain, low tolerance to exercise and heat we finally uncovered an arrhythmia via 30 day cardiac monitor. On November 1st 2021 we uncovered Non Sustained Ventricular Tachycardia. This lead to an Angiogram the next day to rule out a blockage. no blockages were seen or signs of coronary artery. My cardiologist suspected acute myocarditis because of the type of arrhythmia. Since then i have been still symptomatic dealing with irregular heart beats, chest pain, gastritis, brain fog.
Patient was confusing but it sounds like she developed an asthma exacerbation 3 days after Covid vaccine.  Resolved with her normal inhalers and she may have used albuterol more often than usual.  She cannot tell us how long it took for the symptoms to resolve.  She dealt with the symptoms at home and told me about it 2 months later at a routine and unrelated office visit.
Felt sick with some aches.  No fever, no nausea, not much appetite.  Stayed in bed for one full day.  Much better the next morning.  Also, while this is specifically after getting the 2nd shot, I had the identical reaction to the 1st shot six months ago.
Breakthrough case admission after 3 vaccines  Moderna 2/7/21 Lot# 038K20A;  Moderna 3/7/21 Lot# 030A21A;  Moderna 10/27/21 Lot# 017F21A
I got the flu vaccine on 11/14/16 ended up with bronchitis with component of reactive airway disease on 12/22/16. I went to the dr after a week of feeling ill.
Headache centered at back of head and neck; Sore arm at site of shot; Fatigue; Nausea (mild); Slight dizzziness when getting up from bed; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL0142), via an unspecified route of administration at the left arm on 17Jan2021 14:15 at a single dose for covid-19 immunization. The patient has no chronic health conditions or diagnosed illnesses; generally good health. The patient was not pregnant at the time of vaccination. There were no concomitant medications. The patient previously took codeine and experienced allergies: codeine. On 17Jan2021 17: 30, the patient experienced headache centered at back of head and neck, sore arm at site of shot, fatigue, nausea (mild) for about 8 hours, slight dizziness when getting up from bed.  It was reported that it took 36 hrs for all adverse effects to go away. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. Treatment was not received for the adverse events. The vaccine was administered in a hospital. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was recovered on 19Jan2021 05:30.
This spontaneous report as received from a nurse practitioner refers to a 11 month and 2 week old patient of unknown gender. On 14-FEB-2013, the patient was vaccinated intramuscularly (IM) with a 0.5 ml one time dose of VAQTA (Lot # not provided). No concomitant medications reported. No adverse effect reported. Patient's outcome was unknown. Additional information has been requested.
Right arm had mild swelling and erythema measuring 7 cm X 9cm. He was given Cephalexin and Cutivate cream for the cellulitis.
Information has been received from a medical assistant concerning a 68 year old female with diabetes mellitus who on 04-DEC-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23 (Lot 651399/0486F). Concomitant therapy included Metformin. On 04-DEC-2006, the site of injection for the patient was red, swollen, hot to touch, and very hard. The area was sensitive to the touch and the pain made sleeping difficult. The patient also ran a slight temperature. The patient sought unspecified medical attention. At the time of this report, the outcome was unknown. The office requested a lot check be performed on lot 651399/0486F. The records of testing prior to release of the lot in question have been rechecked and were found to be satisfactory. The lot complies with the agency and was released. Additional information has been requested.
Patient 3: dose given >12hrs post vial puncture.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient 3: dose given >12hrs post vial puncture.) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 038K20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021 at 1:11 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient 3: dose given >12hrs post vial puncture.). On 07-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Patient 3: dose given >12hrs post vial puncture.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported  Patient took Vaccine on 07 Dec 2021 and Vial opened on 06 Dec 2021.   This case was linked to MOD-2021-407042, MOD-2021-407134, MOD-2021-407133 (Patient Link).
She experienced swelling at the injection site and sorenes; She experienced swelling at the injection site and sorenes; This is a spontaneous report from a Non-contactable consumer. This consumer reported for a 08 Decade female (friend) patient that:  A 8-decade-old (in her 70s) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. Medical history included hypersensitivity. The patient's concomitant medications were not reported. The patient experienced she experienced swelling at the injection site and soreness from her neck to her wrist on an unspecified date. Outcome of the event was unknown. No follow-up attempts are possible, Information about batch/lot number cannot be obtained. No further information is expected.
Began with soreness at injection site then moved to total arm then left shoulder left back and left chest, developed difficulty breathing, difficulty to take a deep breath continues, dizziness and now a large red splotch on lower right arm and lower left arm.
This spontaneous report as received from a physician and refers to an unspecified number of patients of unknown age and gender. Medical history and concomitant medications were unknown. It was reported that improperly stored dose of VARIVAX (Merck) lot # L018001, expiration date 19-MAY-2017, (dose and route were not reported), was given to unspecified patients on unspecified dates. No adverse effects were reported. It was unknown if the patients sought medical attention. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
Pt recieved covid vaccine around 1320 on 02/10/2021. Short after, pt reported being light headed/dizzy. Pt advised to rest and drink some water. Condition progressed to reported complaints of tingling in lips and cheek area @ 1340. Pt then given one 50 mg diphendyramine capsule. Thirty minutes later, symptoms had improved. Pt advised to have someone drive her home as benadryl causes drowsiness. Will discuss with MD what future plans are for second dose.
Shortness of breath  Dizziness Nausea  Soreness in arm of injection
Fatigue, body ache, headache, chills, and nausea. Tylenol doesn't help much.
Since injection, sore arm around injection site for 4 days so far, site is red, inflamed, hot to the touch, several inches in diameter; The following symptoms began the night of the injection but have already dissipated:  chills, fever of up to 101.8 degrees for two days, body aches, fatigue
Nausea developed within two hours of receiving vaccine.  Chills, sweats, and dizziness developed the next day.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported.  Date of placed in refrigerator was on 18-Nov-2021. There was no temperature excursion. No other events were reported for patient. No treatment information was reported.
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/9/2021 and 4/6/2021. Presented to the ED on 9/24/2021 reports that over the past 2 weeks, he has had a productive cough, nausea, loss of appetite, and progressivley worsening SOB leading to EMS call. Pt tested positive for COVID, on arrival. He was satting 92% on 10L NRB; hypoxia progressed and pt was transition to HFNC 50/50. He was admitted and ended up requiring max HF settings, developing respiratory failure. Decision made to transfer to comfort care, patient expired on 10/3/2021
The patient is a healthy 12 mo old female with a history of eczema who received MMR, Varicella, hep A and PREVNAR vaccines and developed 3 episodes of papular dermatitis with some macules, on day 0, day 3 and day 11. Fever, fatigue, irritability, anorexia was present on day 3 and she continues to have disruption of sleep schedule and increased clinginess. The family did vacation travel out of the area during these episodes. Rash and other nonspec skin eruption.
60% hearing loss/ deafness; Fluid build up in ears; Ear infection; This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS (60% hearing loss/ deafness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEUPRORELIN ACETATE (ELIGARD) for an unknown indication.    On 15-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced DEAFNESS (60% hearing loss/ deafness) (seriousness criterion medically significant), EAR DISCOMFORT (Fluid build up in ears) and EAR INFECTION (Ear infection). The patient was treated with PREDNISONE (oral) at a dose of 40 mg once a day. At the time of the report, DEAFNESS (60% hearing loss/ deafness), EAR DISCOMFORT (Fluid build up in ears) and EAR INFECTION (Ear infection) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had 60% hearing loss/deafness due to fluid buildup and infection in ears that developed shortly after second vaccine on 15-May-1021. Very limited information regarding these events has been provided at this time. Further information is required.   This case was linked to MOD-2021-225579, MOD-2021-225579 (Patient Link).; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information is required.